Andy Jones

Articles

Pharma is moving towards greater patientcentricity – but there are plenty of obstacles and commercial pressures remaining, reports Andrew McConaghie.

News

The appetite among biotechs for IPOs shows no signs of being satisfied, with three more – ADARx, TRex, and Retension – making their intentions known.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.